Medifast Statistics
Total Valuation
Medifast has a market cap or net worth of $353.78 million. The enterprise value is $225.75 million.
| Market Cap | 353.78M |
| Enterprise Value | 225.75M |
Important Dates
The next confirmed earnings date is Monday, April 29, 2024, after market close.
| Earnings Date | Apr 29, 2024 |
| Ex-Dividend Date | Sep 18, 2023 |
Share Statistics
Medifast has 10.90 million shares outstanding. The number of shares has decreased by -3.15% in one year.
| Shares Outstanding | 10.90M |
| Shares Change (YoY) | -3.15% |
| Shares Change (QoQ) | -0.22% |
| Owned by Insiders (%) | 2.70% |
| Owned by Institutions (%) | 97.44% |
| Float | 9.80M |
Valuation Ratios
The trailing PE ratio is 3.57 and the forward PE ratio is 16.90. Medifast's PEG ratio is 1.95.
| PE Ratio | 3.57 |
| Forward PE | 16.90 |
| PS Ratio | 0.33 |
| Forward PS | 0.50 |
| PB Ratio | 1.76 |
| P/FCF Ratio | 2.51 |
| PEG Ratio | 1.95 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1.57, with an EV/FCF ratio of 1.60.
| EV / Earnings | 2.27 |
| EV / Sales | 0.21 |
| EV / EBITDA | 1.57 |
| EV / EBIT | 1.79 |
| EV / FCF | 1.60 |
Financial Position
The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.43 |
| Quick Ratio | n/a |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.15 |
| Debt / FCF | 0.16 |
| Interest Coverage | -50.73 |
Financial Efficiency
Return on equity (ROE) is 53.00% and return on invested capital (ROIC) is 43.66%.
| Return on Equity (ROE) | 53.00% |
| Return on Assets (ROA) | 31.30% |
| Return on Capital (ROIC) | 43.66% |
| Revenue Per Employee | $1.69M |
| Profits Per Employee | $156,806 |
| Employee Count | 634 |
| Asset Turnover | 3.38 |
| Inventory Turnover | 3.42 |
Taxes
In the past 12 months, Medifast has paid $29.38 million in taxes.
| Income Tax | 29.38M |
| Effective Tax Rate | 22.81% |
Stock Price Statistics
The stock price has decreased by -66.49% in the last 52 weeks. The beta is 1.15, so Medifast's price volatility has been higher than the market average.
| Beta (1Y) | 1.15 |
| 52-Week Price Change | -66.49% |
| 50-Day Moving Average | 39.27 |
| 200-Day Moving Average | 66.51 |
| Relative Strength Index (RSI) | 37.62 |
| Average Volume (30 Days) | 387,133 |
Short Selling Information
The latest short interest is 2.66 million, so 24.43% of the outstanding shares have been sold short.
| Short Interest | 2.66M |
| Short Previous Month | 1.94M |
| Short % of Shares Out | 24.43% |
| Short % of Float | 27.16% |
| Short Ratio (days to cover) | 5.83 |
Income Statement
In the last 12 months, Medifast had revenue of $1.07 billion and earned $99.42 million in profits. Earnings per share was $9.10.
| Revenue | 1.07B |
| Gross Profit | 775.85M |
| Operating Income | 126.40M |
| Pretax Income | 128.80M |
| Net Income | 99.42M |
| EBITDA | 144.02M |
| EBIT | 126.31M |
| Earnings Per Share (EPS) | $9.10 |
Balance Sheet
The company has $150.04 million in cash and $22.01 million in debt, giving a net cash position of $128.03 million or $11.75 per share.
| Cash & Cash Equivalents | 150.04M |
| Total Debt | 22.01M |
| Net Cash | 128.03M |
| Net Cash Per Share | $11.75 |
| Equity / Book Value | 201.48M |
| Book Value Per Share | 18.49 |
| Working Capital | 131.73M |
Cash Flow
In the last 12 months, operating cash flow was $147.66 million and capital expenditures -$6.48 million, giving a free cash flow of $141.17 million.
| Operating Cash Flow | 147.66M |
| Capital Expenditures | -6.48M |
| Free Cash Flow | 141.17M |
| FCF Per Share | $12.97 |
Margins
Gross margin is 72.37%, with operating and profit margins of 11.79% and 9.27%.
| Gross Margin | 72.37% |
| Operating Margin | 11.79% |
| Pretax Margin | 12.01% |
| Profit Margin | 9.27% |
| EBITDA Margin | 13.43% |
| EBIT Margin | 11.78% |
| FCF Margin | 13.17% |
Dividends & Yields
This stock pays an annual dividend of $3.30, which amounts to a dividend yield of 10.16%.
| Dividend Per Share | $3.30 |
| Dividend Yield | 10.16% |
| Dividend Growth (YoY) | 3.94% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 36.26% |
| Buyback Yield | 3.15% |
| Shareholder Yield | 13.31% |
| Earnings Yield | 28.10% |
| FCF Yield | 39.90% |
Analyst Forecast
The average price target for Medifast is $61.00, which is 87.87% higher than the current price. The consensus rating is "Hold".
| Price Target | $61.00 |
| Price Target Difference | 87.87% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medifast has an Altman Z-Score of 8.06 and a Piotroski F-Score of 8.
| Altman Z-Score | 8.06 |
| Piotroski F-Score | 8 |